Paragonix Announces World’s First-In-Human Use of BAROguard™ Donor Lung Preservation System by Leading Academic Medical Center

WALTHAM, Mass.–(BUSINESS WIRE)–Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, has successfully completed the world’s first-in-human case utilizing its newest donor lung preservation technology, the BAROguard™ Donor Lung Preservation System, which received FDA 510(k) clearance in August 2023. The groundbreaking case, conducted by Dr. Kunal Patel at Duke University Medical Center, safely protected a pair of donor lungs across 600 miles. The BA
Click here to view original post